Alzheimer’s disease is characterized by intracellular NFTs comprised of tau proteins (Takahashi et al., 2008) as well as tau oligomers (Lasagna-Reeves et al., 2012b). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.